Shield Therapeutics’ pricing will be “key metric” – Proactive Research Analyst
–News Direct– Proactive Research Analyst Robin Davison speaks to Thomas Warner after publishing a new research note on iron defiency-focused commercial-stage specialty pharmaceutical company Shield Therapeutics. Davison gives an overview of what readers can expect…